Clinical trials
Phase 2 Diabetes Mellitus trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 4 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Novo Nordisk A/S | 2 |
| Pfizer | 2 |
| Akros Pharma Inc. | 1 |
| Amgen | 1 |
| Bayer | 1 |
| Biogen | 1 |
| Diamyd Medical AB | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 19 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetic Retinopathy | 2 |
| Glucose Metabolism Disorders | 2 |
| Hyperglycemia | 2 |
| Obesity | 2 |
| Autoimmune Diseases | 1 |
| COVID-19 | 1 |
| Diabetes Mellitus, Lipoatrophic | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.